http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20020583-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-00 |
filingDate | 2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1de1ede11d052d5f921eec15214131d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4ad1b2940213e774425c7985b808573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571a56049700f9445fe2bc753adf02d4 |
publicationDate | 2002-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | PE-20020583-A1 |
titleOfInvention | BENZODIAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS |
abstract | REFERS TO SUBSTITUTE DERIVATIVES OF IMIDAZO [1,5-a] [1,2,4] TRIAZOLO [4,3-d] [1,4] BENZODIAZEPINE; WHERE: R1 IS H, HALOGEN, ALKYL, ALCOXYL, HYDROXYL, CYANE, TRIFLUOROMETHYL, TRIFLUOROMETOXYL, ALKYLTIO; R2 IS COO-ALKYL, ISOXAZOLE, 1,2,4-OXADIAZOL-3-IL, 1,2,4-OXADIAZOL-5-ILO OPTIONALLY SUBSTITUTED BY ALKYL, TRIFLUOROMETHYL, CYCLOALKYL; R3 IS H, ALKYL, (CH2) n-CYCLOALKYL, (CH2) nHALOGEN, (CH2) n-PYRIDN-4-ILO, (CH2) nPHENYL; R IS H, ALKYL; n IS 0-3; EXCEPT FOR THE COMPOUNDS ETHYL-9H-IMIDAZO [1,5-a] [1,2,4] TRIAZOLO [3,4-d] [1,4] BENZODIAZEPINE-10-CARBOXYLATE, AMONG OTHERS; PREFERRED COMPOUNDS ARE ETHYL-3-METOXY-9H-IMIDAZO [1,5-a] [1,2,4] TRIAZOLO [4,3-d] [1,4] -BENZODIAZEPINE-10-CARBOXYLATE; ETHYL-3-METHOXY-7-METHYL-9H-IMIDAZO [1,5-a] [1,2,4] TRIAZOLO [4,3-d] [1,4] -BENZODIAZEPINE-10-CARBOXYLATE; 10- (3-CYCLOPROPYL-1,2,4-OXADIAZOL-5-IL) -3-METOXY-9H-IMIDAZO [1,5a] [1,2,4] TRIAZOLO [4,3-d] [1, 4] BENZODIAZEPINE, AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. THE COMPOUNDS HAVE AFFINITY AND SELECTIVITY FOR THE GABA RECEPTOR BINDING SITES TO SUBUNIT O5 AND MAY BE USEFUL FOR THE TREATMENT OF COGNITIVE DISORDERS SUCH AS ALZHEIMER'S DISEASE |
priorityDate | 2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.